Astera Labs, Inc. $ALAB Stock Purchased by Park Avenue Securities LLC

Park Avenue Securities LLC grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 7.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 58,995 shares of the company’s stock after buying an additional 4,281 shares during the period. Park Avenue Securities LLC’s holdings in Astera Labs were worth $21,000,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of ALAB. Greenleaf Trust boosted its holdings in Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after acquiring an additional 36 shares during the period. Parkside Financial Bank & Trust grew its position in Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after acquiring an additional 41 shares during the last quarter. Integrated Advisors Network LLC grew its position in Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after acquiring an additional 45 shares during the last quarter. Glenmede Trust Co. NA increased its stake in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the period. Finally, Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the second quarter worth $25,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Stock Up 0.9%

Shares of NASDAQ:ALAB opened at $259.51 on Tuesday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $45.02 billion, a P/E ratio of 128.47 and a beta of 3.68. The business’s 50 day moving average is $310.76 and its 200 day moving average is $252.11.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company’s stock, valued at $32,872,551. The trade was a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 408,558 shares of company stock worth $127,306,034. Insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ALAB. Citigroup downgraded Astera Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 9th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Friday, October 9th. Jefferies Financial Group raised their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Morgan Stanley raised their price target on shares of Astera Labs from $240.00 to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Finally, Susquehanna lifted their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Eleven research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.